Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.84 -0.27 (-2.43%)
At close: Oct 23, 2026 · 4:00 PM EDT

Monte Rosa Therapeutics (GLUE) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Monte Rosa Therapeutics (GLUE) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Monte Rosa Therapeutics 923.85 Mn 335.67 Mn - 51.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.94 Mn
Mar 31, 2026 72.87 Mn
Dec 31, 2025 89.36 Mn
Sep 30, 2025 104.76 Mn
Jun 30, 2025 46.05 Mn
Mar 31, 2025 39.37 Mn
Dec 31, 2024 37.25 Mn
Sep 30, 2024 70.52 Mn
Jun 30, 2024 14.82 Mn
Mar 31, 2024 67.31 Mn
Dec 31, 2023 43.50 Mn
Sep 30, 2023 45.10 Mn
Jun 30, 2023 25.00 Mn
Mar 31, 2023 97.33 Mn
Dec 31, 2022 47.70 Mn
Sep 30, 2022 90.30 Mn
Jun 30, 2022 40.00 Mn
API Access

Monte Rosa Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GLUE&period=max&api_key=YOUR_API_KEY